XPO Logistics appoints AnnaMaria DeSalva to board
Ms. DeSalva is global chief communications officer for DuPont, where she is responsible for corporate brand strategy and stakeholder communications, most recently related to the merger with Dow.
Prior to joining DuPont in 2014, Ms. DeSalva served as head of corporate affairs for biopharmaceutical innovation at Pfizer, a role that included the integration of Pfizer's $68 billion acquisition of Wyeth.
Earlier, she served as an advisor to the U.S. Food and Drug Administration, and led the global healthcare practice of Hill & Knowlton.
For Bristol-Myers Squibb, Ms. DeSalva led global public affairs for the oncology business with a focus on European market development, and served as the director of the Bristol-Myers Squibb Foundation.
Ms. DeSalva graduated with honors from The College of William & Mary in Williamsburg, Va.
She has completed the Harvard School of Public Health's executive education program in risk communication, and the Advanced Health Leadership Program jointly offered by the University of California at Berkeley and Pompau University in Barcelona, Spain.
In addition to XPO Logistics, Ms. DeSalva serves on the board of governors of Argonne National Laboratory, a science and engineering research laboratory of the U.S. Department of Energy, and is a member of its compensation and nominating committees.